Pinned Tweet
Thrilled to see our new SVIN practice update highlighted on the main stage at #SVIN2025 by @svinsociety President Dr. Thanh Nguyen! 🙌🧠
So grateful to @oozaidat and all my mentors 🙏.. proud to contribute to this important work. 🚀💙
#Stroke #NeuroIntervention @SVINJournal
Amit Chaudhari MD retweeted
Just weeks after approval in China, asundexian is now FDA-approved, ushering in a new class of therapies for stroke prevention!
A gratifying milestone after years of research and global collaboration.
Congratulations to Bayer and the entire OCEANIC-STROKE team!
@McmasterStroke
🚨The FDA has approved asundexian for secondary stroke prevention in patients with non-cardioembolic ischemic stroke or high-risk TIA.🚨
Our latest article explores the approval, featuring expert insights from recent interviews with @mike_sharma2 and @Ash_Shoamanesh on the OCEANIC-STROKE trial and the clinical implications.
📖Read more: ow.ly/W6Uy5105j8r
Intended for healthcare professionals.
#Stroke #FDAApproval #Neurology
Amit Chaudhari MD retweeted
Thrilled to announce that Insera’s CLEAR™ Aspiration System featuring #CyclicalAspiration has received U.S. #FDA 510(k) clearance for the peripheral vasculature. Thank you to our physicians, partners & the #MedTech community who made this possible. See => prn.to/4xPX8sA
🤔 Is 3 months of DAPT enough after flow diversion?
In this multicenter registry analysis of 721 patients treated with Pipeline Shield, approximately 3 months of DAPT was not associated with increased ischemic complications compared with prolonged therapy. These findings suggest consideration of a shorter DAPT regimen in selected patients, although prospective validation is needed. 🧠
🔗 Read more at bit.ly/3WDkMeS
Is factor XIa a miracle after oceanic-stroke??
"6.2% of the asundexian group versus 8.4% of the placebo group, with a cause-specific hazard ratio of 0.74 ([95% CI, 0.65–0.84]; P<0.001). The number needed to treat was 53 at 1 year and 43 at 2 yrs. "
Meh
ahajournals.org/doi/full/10.….
Amit Chaudhari MD retweeted
Pioneer of endovascular neurosurgery and innovator Dr. @oozaidat will be joining with most recent updates and cutting edge of the pivotal @SealTrial at the @brainconferenc1 in December! Must look forward to it
#endovascular #aneurysm #stroke #brain
Amit Chaudhari MD retweeted
"Access to life-saving treatment should not be determined by where a patient lives."
Santiago Ortega-Gutiérrez, our director, as President of SVIN. Mission Thrombectomy convened with BCIU, Philips and @Medtronic_NV @Medtronic.
Full news from @svinsociety:
prnewswire.com/news-releases…
New JNIS | A coated flow diverter compatible with 0.017 inch microcatheters
In this prospective multicenter study of the AUCURA flow diverter:
96.99% achieved successful occlusion at 12 months
95.49% achieved complete occlusion
Major stroke or neurological death occurred in 1.40%
A very interesting next-generation FD concept combining a low-profile delivery system, antithrombotic coating, and strong aneurysm occlusion results.
🔗 bit.ly/47khyz6
#JNIS #FlowDiversion #Aneurysm #Neurointervention
Von Vascular's preclinical data about the Algo aspiration pump is very promising.
Let's see how it does in human patients.. excited
neuronewsinternational.com/v…
164
Amit Chaudhari MD retweeted
In a recent @JNIS_BMJ study, @fdianamd et al evaluated adding rosuvastatin to aspirin to improve #aneurysm healing after flow diversion in a rabbit model. Here, Diana outlines key findings, signals that warrant caution, and where research should go next
neuronewsinternational.com/c…
Amit Chaudhari MD retweeted
FIB-CAS Prospect is a collaborative, multi-site effort to answer an important clinical question in patients with ICAS and AF. One year in & more enrollments ahead. Grateful to every investigator and coordinator helping move the study forward 🧠
#Stroke #ICAS #AtrialFibrillation
Amit Chaudhari MD retweeted
The HALF-IT score, novel simplified MRI-based score for selecting candidates for basilar artery mechanical thrombectomy
@oozaidat @Mo_majali91 @NeuroIRdoc
New Research: The HALF-IT score: proposing a simplified mechanical thrombectomy triage tool for basilar artery occlusion www.frontiersin.org/articles/10.3389/fneur.2026.1915436 #FrontiersIn #Neurology
Amit Chaudhari MD retweeted
And here's another meta-analysis yet again showing benefit (mRS 0-2) when giving TPA/TNK in the 4.5-24 hour window based on penumbral imaging.
When is this going to become mainstream?
Thrombolysis in the Delayed Treatment Window for Acute Ischemic Stroke: Updated Systematic Review and Meta-Analysis | @StrokeAHA_ASA
ahajournals.org/doi/abs/10.1…
Amit Chaudhari MD retweeted
This review indicates that there is no clear, well-supported recommendation to administer DDAVP to patients with antiplatelet-associated #ICH. Anfd there was also a soft signal towards more thromboembolic events.
link.springer.com/article/10…
Amit Chaudhari MD retweeted
Comparing superbore .08x aspiration vs cyclical aspiration with .07x systems.
Less distal embolization with superbore
link.springer.com/article/10…
1
207
Amit Chaudhari MD retweeted
In the landmark CREST-2 study, revascularization did not influence cognition in patients with otherwise asymptomatic carotid stenosis. Read the key results: jwat.ch/4dfphlh
Amit Chaudhari MD retweeted
Mark your calendars for these important dates pertaining to #Match2027. Be sure not to miss the following ERAS submission dates, leading up to the #neurointerventional match!
Amit Chaudhari MD retweeted
SEAL Commercial update - India, here we go!
SEAL has received regulatory approval in India!
Thank you to our local partners and the Galaxy team for making this milestone possible.
#SEAL #GalaxyTherapeutics #India
Super large bore aspiration catheters (SLACs) in stroke thrombectomy:
📊 A systematic review of 532 patients found ~92% thrombus access, ~55% first-pass effect, and ~81% final near-complete reperfusion, with low complication rates.
🔬 Larger prospective trials are still needed to define their optimal role.
Read more here: bit.ly/4hFDTMk
Amit Chaudhari MD retweeted
A tremendous honor to work with everyone with collaborative expertise here at USC!
Incredible neurovascular program @KeckMedicineUSC featuring #neurosurgery, #neurology & #radiology. David L our superstar #stroke #neurologist starts things off by casting a vision of an NV Operating System. #Brilliant @NeimanHPI @SNISinfo #Neuro



























